📌 Key Takeaways
- Topic: Mica Powder vs Silica: Properties and Applications Compared
- Keywords: silica anti settling agent
- Published: 2026-11-20 12:01:15
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Spherical Alumina vs Spherical Silica: Thermal Fillers Compared
- Matting Agent for Coatings: Types, Selection Guide and Performance Comparison
- Silica Flatting Agent: Gloss Reduction Mechanism, Grades and Applications
- Submicron Spherical Silica: Specifications and Uses in Underfill and Advanced Packaging
- 68. Zhang Y., Ye Z., He R., Li Y., Xiong B., Yi M., Chen Y., Liu J., Lu B. Bovine serum albumin-based and dual-responsive targeted hollow mesoporous silica nanoparticles for breast cancer therapy. Colloids Surf. B Biointerfaces. 2023;224:113201. doi: 10.1016/j.colsurfb.2023.113201. [ DOI ] [ PubMed ] [ Google Scholar ]
- Silica Manufacturers List: Global and Chinese Producers by Product Type
- 32. Voicu S.N.P., Dinu D., Sima C., Hermenean A., Ardelean A., Codrici E., Stan M.S., Zărnescu O., Dinischiotu A. Silica nanoparticles induce oxidative stress and autophagy but not apoptosis in the MRC-5 cell line. Int. J. Mol. Sci. 2015;16:29398-29416. doi: 10.3390/ijms161226171. [ DOI ] [ PMC free piece ] [ PubMed ] [ Google Scholar ]
Silica Market Size 2026: Global Value, Growth Rate and Key Segments
What is silica (SiO₂)?
silicon oxide anode 107. Iveson S.M., Litster J.D., Hapgood K., Ennis B.J. Nucleation, growth and breakage phenomena in agitated wet granulation processes: A review. Powder Technol. 2001;117:3-39. doi: 10.1016/S0032-5910(01)00313-8. [ DOI ] [ Google Scholar ]
What is the difference between fumed silica and precipitated silica?
silica exporter
What drives silica raw material prices?
ultra pure silica The skin is our largest organ, which consists of three layers: the epidermis, dermis, and hypodermis. Owing to its big surface zone, it also serves as an essential gateway for drug administration [ 25 ], which is fitting for both local (dermal) or systemic (transdermal) therapy [ 25, 56 ]. In spite of the popularity of this administration route, it is a challenge to get the API into deeper layers of the skin. The outermost layer of the epidermis, the stratum corneum, is the biggest hurdle to molecular penetration [ 25, 56 ]. However, the molecules must be absorbed through the capillaries of the dermis to achieve a systemic impact, which can be facilitated employing nanocarriers [ 56 ]. In addition, sweat glands or hair follicles can be effective alternative routes for the molecules to enter the deeper layers of the skin [ 25, 56 ]. In summary, it can be called as the transappendageal route. Among physicochemical properties, particle size is one of the most vital factors influencing absorption. Particles in the range between 200 and 300 nm are suitable for local treatment of the skin in diseases such as atopic dermatitis [ 25 ] since particles larger than 75 nm do not pass through the stratum corneum [ 25 ]. Smaller particles (approximately 50 nm) are suitable for systemic treatment [ 25 ], and on the whole, it can be said that nanoparticles with a diameter smaller than 25 nm can penetrate the skin most effectively, so they can be used for transdermal drug administration with an appropriate formulation [ 56 ]. By controlling the size of the nanocarrier, they penetrate to different depths in the skin. From the element of surface characteristics, cationic amino-functionalized MSNs show more efficient penetration into deeper layers of the skin than the particles with anionic surfaces of the same size [ 25 ]. The use of MSNs as a drug carrier may improve aqueous solubility, stability, and skin penetration of the drug [ 61 ]. In a research, gels containing MSN were prepared by employing distilled water to form the base, adding the gelling agent (Poloxamer 407), and adding HPMC to enhance the viscosity [ 83 ]. In another publication, MSN containing oleogels were prepared with sunflower oil and the addition of colloidal silicon dioxide as a gelling agent [ 61 ]. According to in vitro experiments, the gel matrix also affected the drug release kinetics [ 61, 83 ]. Slower drug release was observed in the case of gels containing loaded MSNs, compared to the free carriers, and the outcomes demonstrated close to zero-order release kinetics [ 61 ]. According to in vitro biocompatibility studies, this gel complex did not show any evidence of cytotoxicity on dermal fibroblast cells. Moreover, according to in vivo dermal safety studies, it has been proven that this preparation does not cause skin irritation during application, and so this formulation can be considered a safe product [ 61 ].
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.